TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland

Health and Safety Executive (HSE) grants Authorization Nos.: GB-2016-1042 and NI-2026-1350

FREDERICK, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced that Health and Safety Executive (HSE), Great Britian’s national regulator for health and safety, has granted official authorization for its Binary Ionization Technology (BIT) solution and the SteraMist iHP brand of disinfection equipment. The BIT Solution is now formally approved as a biocidal product for use in Great Britain, which includes England, Scotland, and Wales under Regulation 528/2012 GB. A separate approval was also received for Northern Ireland under Regulation (EU) No. 528/2012.

This milestone marks a significant achievement for TOMI, as it paves the way for expanding the availability of BIT and SteraMist products in both Great Britain and Northern Ireland. The BIT solution is approved under Regulation 528/2012 for room fogging and handheld direct spray applications. It is intended for use as a microbial disinfectant on surfaces, walls, floors, furniture, and rooms across various sectors, including healthcare, industrial, commercial, hospitality, and institutional settings.

Elissa J. Shane, COO of TOMI, stated, “This not only enhances our market footprint but also reinforces our commitment to providing innovative solutions that meet rigorous compliance, safety, and efficacy standards. We are optimistic that our separate application under the EU Biocidal Products Regulation (BPR) for the European Union will also be approved this year, opening doors in additional countries across Europe.”

The BIT solution is designed for disinfection of all dry, pre-cleaned, hard, non-porous, non-food contact surfaces in spaces such as pharmaceutical manufacturing clean rooms, tissue labs, laboratories, animal research facilities, hotel rooms, cruise ships, and recreational facilities.

The following efficacy claims have been established for TOMI’s BIT solution in Great Britain:

TOMI’s SteraMist products utilize a low percentage of Hydrogen Peroxide as the only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™), which creates a germ-killing aerosol that functions like a non-caustic gas. These products are designed for a wide range of applications, including hospitals, medical facilities, schools, restaurants, military barracks, and more.

About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world^®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services serving the food safety sector. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:  

John Nesbett/Rosalyn Christian  

IMS Investor Relations  

tomi@imsinvestorrelations.com